Pediatric Drug Safety and Medication Use
A special issue of Pharmacy (ISSN 2226-4787).
Deadline for manuscript submissions: closed (31 October 2022) | Viewed by 2738
Special Issue Editor
Interests: pediatrics; obesity; medication use; pharmacy education
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
It is a known fact that pediatric patients are the most vulnerable to medication errors. Such medication errors may be a result of human or system flaws, and human errors may occur at the stage of medication ordering, medication preparation, compounding of medications for children, or administration of medications. At times, limited clinical data require specialized training and education for the care of pediatric patients. Such errors may lead to harm to the child, potentially even death. The pharmacist plays a critical role in ensuring the safety of medication use in pediatric patients, not only on an individual basis, but also in the systems that provide care for the most vulnerable population.
We invite you to share your experiences, evaluations, innovations, or any service evaluation or research you have undertaken in relation to the role of medication safety in pediatric patients. Various approaches exist for care in a variety of healthcare settings, including acute care, ambulatory care, community practice, and the development of systems or processes in the medication use process. We hope this Special Issue will inspire pharmacists and researchers to share their own practices and adopt new approaches to innovate to improve pediatric drug safety.
Dr. Sandra Benavides
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- medication safety
- drug errors
- adverse drug events
- computerized prescriber order entry
- comprehensive medication management
- medication use process
- drug use errors
- high-alert drugs
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
